Patents by Inventor Delphine Levy

Delphine Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PROVIDING CONTRACEPTION
    Publication number: 20200316091
    Abstract: The invention relates to a method for providing contraception in a woman, wherein the woman is subjected to hormonal combined contraceptive but experiments at least one misuse of said hormonal combined contraceptive and wherein the method comprises administering ulipristal acetate or a metabolite thereof within 120 hours after said at least one misuse and resuming the hormonal combined contraceptive within 24 hours after the intake of ulipristal acetate in said woman.
    Type: Application
    Filed: April 3, 2020
    Publication date: October 8, 2020
    Inventors: Camille BANH, Pascale BORENSZTEIN, Annabelle GLASIER, Delphine LEVY-GOMPEL, Catherine MONTEIL
  • COPPER INTRAUTERINE DEVICE
    Publication number: 20190008763
    Abstract: The invention relates to a copper contraceptive intrauterine system (IUS) with a flexible frame, which system is further capable of releasing a selective progesterone receptor modulator (SPRM), such as ulipristal acetate, for reducing or preventing bleeding side effects.
    Type: Application
    Filed: September 7, 2018
    Publication date: January 10, 2019
    Inventors: Andre ULMANN, Erin GAINER, Delphine LEVY, Christine Seguin, Florian Battung, Regine SITRUK-WARE
  • Method for scheduling ovulation
    Patent number: 9855282
    Abstract: The invention relates to a method for scheduling ovulation in a female subject, which method comprises administering ulipristal acetate (UPA) to the female subject during the follicular phase.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: January 2, 2018
    Assignee: Laboratoire HRA-Pharma
    Inventors: Delphine Levy, Erin Gainer
  • Ulipristal acetate for prevention and treatment of breast tumors
    Patent number: 9814732
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: November 14, 2017
    Assignees: Laboratoire HRA-PHARMA, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer, Anne Gompel, Patricia Forgez, Laudine Desreumaux-Communal
  • Method for providing regular contraception
    Publication number: 20170136036
    Abstract: The invention relates to a method for providing regular contraception to a woman. Said method comprises administering a daily contraceptive amount of ulipristal acetate or a metabolite thereof over a period of at least 21 consecutive days.
    Type: Application
    Filed: July 2, 2015
    Publication date: May 18, 2017
    Inventors: Delphine LEVY, Erin GAINER, Andre ULMANN
  • METHOD FOR SCHEDULING OVULATION
    Publication number: 20170056417
    Abstract: The invention relates to a method for scheduling ovulation in a female subject, which method comprises administering ulipristal acetate (UPA) to the female subject during the follicular phase.
    Type: Application
    Filed: November 15, 2016
    Publication date: March 2, 2017
    Inventors: Delphine LEVY, Erin GAINER
  • ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS
    Publication number: 20170014426
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Application
    Filed: July 29, 2016
    Publication date: January 19, 2017
    Inventors: Michele RESCHE-RIGON, Delphine LEVY, Erin GAINER, Anne GOMPEL, Patricia FORGEZ, Laudine DESREUMAUX-COMMUNAL
  • Method for scheduling ovulation
    Patent number: 9522154
    Abstract: The invention relates to a method for scheduling ovulation in a female subject, which method comprises administering ulipristal acetate (UPA) to the female subject during the follicular phase.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: December 20, 2016
    Assignee: LABORATOIRE HRA-PHARMA
    Inventors: Delphine Levy, Erin Gainer
  • METHOD FOR SCHEDULING OVULATION
    Publication number: 20160022697
    Abstract: The invention relates to a method for scheduling ovulation in a female subject, which method comprises administering ulipristal acetate (UPA) to the female subject during the follicular phase.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Delphine LEVY, Erin GAINER
  • COPPER INTRAUTERINE DEVICE
    Publication number: 20150320766
    Abstract: The invention relates to a copper contraceptive intrauterine system (IUS) with a flexible frame, which system is further capable of releasing a selective progesterone receptor modulator (SPRM), such as ulipristal acetate, for reducing or preventing bleeding side effects.
    Type: Application
    Filed: December 13, 2013
    Publication date: November 12, 2015
    Inventors: André ULMANN, Erin GAINER, Delphine LEVY, Christine SEGUIN, Florian BATTUNG, Regine SITRUK-WARE
  • METHOD FOR POST COITAL CONTRACEPTION IN OVERWEIGHT OR OBESE FEMALE SUBJECTS USING ULIPRISTAL ACETATE
    Publication number: 20150174141
    Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
    Type: Application
    Filed: March 4, 2015
    Publication date: June 25, 2015
    Inventors: Delphine Levy, Andre Ulmann, Henri Camille Mathe, Erin Gainer
  • METHOD FOR POST COITAL CONTRACEPTION IN OVERWEIGHT OR OBESE FEMALE SUBJECTS USING ULIPRISTAL ACETATE
    Publication number: 20150157643
    Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
    Type: Application
    Filed: January 9, 2015
    Publication date: June 11, 2015
    Inventors: Delphine Levy, Andre Ulmann, Henri Camille Mathe, Erin Gainer
  • COMBINATION OF SELECTIVE PROGESTERONE-RECEPTOR MODULATORS AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    Publication number: 20150150888
    Abstract: The invention relates to a pharmaceutical composition combining a selective progesterone receptor modulator (SPRM), such as ulipristal acetate, and one or more non-steroidal anti-inflammatory compounds, in particular in a method of regular contraception, or in emergency or on-demand contraception.
    Type: Application
    Filed: February 28, 2013
    Publication date: June 4, 2015
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer
  • ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS
    Publication number: 20150133418
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Application
    Filed: May 24, 2013
    Publication date: May 14, 2015
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer, Anne Gompel, Patricia Forgez, Laudine Desreumaux-Communal
  • Method for post coital contraception in overweight or obese female subjects using ulipristal acetate
    Patent number: 8962603
    Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: February 24, 2015
    Assignee: Laboratoire HRA-Pharma
    Inventors: Delphine Levy, Andre Ulmann, Henri Camille Mathe, Erin Gainer
  • METHOD FOR POST COITAL CONTRACEPTION IN OVERWEIGHT OR OBESE FEMALE SUBJECTS USING ULIPRISTAL ACETATE
    Publication number: 20130210788
    Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
    Type: Application
    Filed: December 1, 2010
    Publication date: August 15, 2013
    Applicant: LABORATOIRE HRA-PHARMA
    Inventors: Delphine Levy, Andre Ulmann, Henri Camille Mathe, Erin Gainer
  • ONCE-A-MONTH METHOD OF CONTRACEPTION
    Publication number: 20130090318
    Abstract: The invention provides a method for providing contraception in a woman, wherein the woman is administered with a progestogen-only contraception composition once-a-month between the 1st and the 10th day of the woman menstrual cycle. It is further provided a system for reminding a woman of taking such contraceptive composition.
    Type: Application
    Filed: June 24, 2011
    Publication date: April 11, 2013
    Applicant: LABORATOIRE HRA-PHARMA
    Inventors: Andre Ulmann, Erin Gainer, Delphine Levy